What a load of rot. You really are getting carried away with yourself there. A double-blinded trial is nothing like your experience in 'multiple industries and confidential programs'. Blinding means NOBODY knows who is on the drug and who isn't until the codes are cracked. There will clearly be no 'informal discussion' between trial facilities and NEU staff because NONE of them have this information. Likewise the social media comments are uninformed, mouse study results are effectively meaningless for humans (or else the trial would be in mice), and the IGF-1 trial results weren't really all that impressive. 'Big Pharma' will be interested if the phase 2 results look interesting and not before. Calm down and have a cold shower.
agm today, page-19
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |